MOH — authorised 26 November 2018
- Marketing authorisation holder: LOXO ONCOLOGY INC
- Status: likely_approved
MOH authorised Vitrakvi on 26 November 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 26 November 2018.
LOXO ONCOLOGY INC holds the UAE marketing authorisation.